Sharemaestro Newsreel

Bronstein, Gewirtz & Grossman, LLC Is Investigating Molina Healthcare, Inc. (MOH) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Molina Healthcare, Inc. (MOH) for corporate wrongdoing. The firm encourages shareholders who purchased Molina securities before February 5, 2025, and still hold them, to contact them to assist with the investigation. The investigation aims …

CVS Health (CVS) Surpasses Market Returns: Some Facts Worth Knowing

CVS Health (CVS) recently closed at $110.60, outperforming the S&P 500's daily gain and demonstrating strong performance over the past month. The company is set to release its earnings on August 5, 2026, with anticipated EPS and revenue growth. CVS Health currently holds a …

UnitedHealth Group Inc (UNH) Stock Up 3.5% and Still Undervalued -- GF Score: 86/100

UnitedHealth Group Inc's (UNH) stock rose 3.5% to $436.35, yet remains 27.8% undervalued according to its GF Value™ of $604.20. The company boasts a strong GF Score™ of 86/100, driven by high momentum and profitability ranks, despite its P/E ratio being above its historical …

Clover Health CEO Jamie Reynoso sells $21,920 in CLOV stock By Investing.com

Clover Health's Medicare Advantage CEO, Jamie L. Reynoso, sold 4,839 shares of CLOV stock for $21,920, at a weighted average price of $4.53 per share, according to a Rule 10b5-1 trading plan. This transaction occurred after Clover Health shares surged 73% in six months, …

Cigna Group stock trades steadily as health benefits growth supports margins

Cigna Group's stock reflects strong performance driven by disciplined underwriting and expanding Evernorth health services. The company reported significant revenue growth, resilient margins, and continuous investments in technology and data, positioning it well in the competitive US health insurance market. Diversified membership across commercial …

Centene stock trades steady as Medicaid membership returns to growth

Centene's stock is showing stability as its Medicaid and marketplace membership base recovers following the redetermination cycle. The company has navigated membership shifts, demonstrating efforts to align with 2025 guidance and improve margin trends through operational efficiencies and strategic investments. Investors are closely watching …

Unitedhealth Group Inc Stock (UNH) Moved Up by 3.02% on Jul 21: Drivers Behind the Movement

UnitedHealth Group Inc (UNH) saw its stock price rise by 3.02% due to a stronger-than-expected quarterly earnings report, driven by growth in its Optum health services segment and effective medical cost management. The company also benefited from stable Medicare Advantage reimbursement rates, a resilient …

ALIGNMENT HEALTHCARE INVESTOR ALERT: Bragar Eagel & Squire,

Bragar Eagel & Squire, P.C. is investigating potential claims against Alignment Healthcare, Inc. (NASDAQ:ALHC) following allegations of financial manipulation. A former executive filed a whistleblower lawsuit claiming the company misclassified operating expenses as capital expenditures to inflate its adjusted EBITDA and stock price. Following …

Molina Healthcare stock trades steadily as Medicaid membership and margins underpin valuation

Molina Healthcare (MOH) stock is trading steadily, supported by strong revenue growth and disciplined cost management in its Medicaid and marketplace segments. The company reported a 17% revenue increase and 25% net income growth in fiscal 2023, while expanding its membership base to nearly …

PGNY Maintained by Canaccord Genuity -- Price Target Raised to $36

Canaccord Genuity has maintained a "Buy" rating for Progyny (PGNY) and raised its price target to $36.00, reflecting increased confidence in the healthcare company's business model, particularly in fertility and family-building benefits. Despite the positive outlook and a high GF Score™ of 94/100, the …

Impact in action: The Cigna Group’s commitment to better health for all

The Cigna Group released its 2025 Corporate Impact Report, highlighting efforts across four pillars: Healthy Society, Healthy Workforce, Healthy Environment, and Healthy Company. Key achievements include reducing prescription drug costs, increasing employee volunteer hours to 114,000, providing $52.2 million in charitable contributions, and achieving …

Cvs stock reaches 52-week high at 109.0 USD

CVS Health Corp's stock has hit a new 52-week high of $108.97, reflecting strong investor confidence and an 81% total return over the past year. Despite its current valuation, InvestingPro analysis suggests the stock is undervalued with additional upside potential. Recent developments include a …

UnitedHealth Stock: Is It Headed for $500?

UnitedHealth Group (UNH) has seen significant stock growth, rising nearly 50% in the past year, driven by strong Q2 results that surpassed analyst estimates. The company reported $112 billion in revenue and adjusted EPS of $6.38, and has upgraded its full-year guidance to $19.50-$20.00. …

Cognizant Lands Centene Mega Deal Worth Over $500 Mn: Report

Cognizant has reportedly secured a mega deal with Centene, a healthcare company, valued at over $500 million. This significant contract underscores Cognizant's continued presence and success in securing large-scale projects within the healthcare sector.

Mizuho Adjusts Price Target on UnitedHealth Group to $493 From $470, Maintains Outperform Rating

Mizuho has increased its price target for UnitedHealth Group (UNH) to $493 from $470, while reiterating an Outperform rating on the stock. This adjustment reflects a positive outlook from the analytical firm regarding the healthcare giant's future performance. The article also lists several other …

JPMorgan Adjusts Price Target on UnitedHealth Group to $516 From $466, Maintains Overweight Rating

JPMorgan has increased its price target for UnitedHealth Group (UNH) to $516 from $466, while reaffirming an Overweight rating on the stock. This adjustment reflects an updated outlook from the financial institution regarding the healthcare giant's valuation. The article also notes other analysts' recent …

Cognizant Wins Multi-Year Centene Deal That Could Touch $1 Billion

Cognizant has secured a multi-year technology services deal with US health insurer Centene Corp, reportedly worth between $500 million and $1 billion. This agreement is expected to significantly bolster Cognizant's healthcare business by leveraging its TriZetto platform and new AI frameworks like Agentic AI. …

Cognizant bags over $500 million Centene deal, deepens AI push in healthcare

Cognizant has secured a multi-year technology services contract worth over $500 million, potentially reaching $1 billion, from US health insurer Centene Corp. This deal reinforces Cognizant's position in the healthcare technology market and highlights CEO Ravi Kumar's strategy to expand the company's AI-led healthcare …

Commerzbank Aktiengesellschaft FI Acquires 47,646 Shares of CVS Health Corporation $CVS

Commerzbank Aktiengesellschaft FI significantly increased its stake in CVS Health Corporation, purchasing an additional 47,646 shares in Q1, raising its total holdings to 102,099 shares valued at $7.33 million. This increase follows CVS Health's stronger-than-expected Q1 earnings, with EPS of $2.57 and revenue of …

Dimensional Fund Advisors LP Increases Stake in CVS Health Corporation $CVS

Dimensional Fund Advisors LP significantly increased its stake in CVS Health Corporation by 3.0% in Q1 2026, bringing its total holdings to 7.2 million shares valued at $516.8 million. This increase follows CVS Health's strong first-quarter performance, where it exceeded EPS and revenue expectations …

Cognizant bags mega deal from Centene, likely worth over $500 million

Cognizant has secured a multi-year technology services deal from US health insurer Centene Corp, reportedly worth over $500 million and potentially up to $1 billion. This deal marks a significant win for Cognizant, especially as Centene had previously restructured a major agreement with them …

Humana Inc. $HUM Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp significantly reduced its stake in Humana Inc. (NYSE:HUM) by 70.6% in the first quarter, selling 1,479,679 shares and now owning 614,891 shares valued at $106.6 million. Despite this, other institutional investors have either increased or initiated positions in …

Molina Healthcare (MOH) To Report Earnings Tomorrow: Here Is What To Expect

MOH stock holds steady as Molina Health Care awaits fresh catalysts

Molina Healthcare (MOH) stock remains stable, driven by its latest verifiable company backdrop centered on reported quarterly metrics and market valuation. The article emphasizes that investors should focus on concrete operating data such as premium revenue, medical care ratios, membership trends, and earnings per …

Smart Money Is Buying Centene Corp. (CNC)

Institutional investors significantly increased their positions in Centene Corp. (CNC) according to recent 13F filings, indicating strong "smart money" buying activity. Notable investors like Bill Nygren, Cliff Asness, David Einhorn, and Steve Cohen (who initiated a new position) purchased shares, suggesting conviction in Centene's …

ALHC SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

Kirby McInerney LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) regarding potential securities laws violations. This follows a whistleblower lawsuit alleging that Alignment Healthcare manipulated its finances by misclassifying operating expenses as capital expenditures, artificially inflating its stock price and executive compensation. The firm …

Guardant Health Surges 53% on UnitedHealth Coverage Deal — "Single-Drop Blood Test for Cancer" Becomes Reality

Guardant Health's stock has surged over 53% this year following strong first-quarter results and a significant partnership with UnitedHealth. This deal expands insurance coverage for their "Guardant Shield" colorectal cancer screening service, pushing commercialization expectations to a peak. Analysts anticipate further growth as the …

Humana Inc (HUM) pushes 12-week rebound to 86.3%

The healthcare-plans stock is trading with an active trend, though relative strength remains moderate rather than emphatic.

Centene (NYSE: CNC) grants 3,155 restricted stock units to director Tyler

Centene Corporation (NYSE: CNC) director Lauren M. Tyler was granted 3,155 restricted stock units on July 17, 2026, as equity compensation. These units are set to vest in full on the date of the company's 2027 annual meeting of stockholders, increasing Tyler's direct holdings …

Public Storage Operating Company Completes Offering of $400 Million 4.700% Senior Notes Due 2032 and $500 Million 5.150% Senior Notes Due 2036

Public Storage Operating Company, a subsidiary of Public Storage, has completed its offering of $400 million in 4.700% Senior Notes due 2032 and $500 million in 5.150% Senior Notes due 2036. The notes are guaranteed by Public Storage and are direct, unsecured, and unsubordinated …

Block & Leviton probes Alignment Healthcare for alleged securities violations after whistleblower lawsuit.

Block & Leviton is investigating Alignment Healthcare (ALHC) for alleged securities violations, stemming from a whistleblower lawsuit. The lawsuit claims the company manipulated financial results to inflate its stock price and executive compensation. This follows a significant 16.72% stock drop after the lawsuit news, …

Molina Healthcare Q2 2026 Earnings Preview — July 22, Street Expects $1.40 EPS

Molina Healthcare is expected to report a sharp deceleration in profitability for Q2 2026, with analysts forecasting earnings of $1.40 per share on $10.78 billion in revenue, a significant drop from the previous year. Analyst sentiment has deteriorated, with consensus EPS estimates declining due …

UNC Health, Humana End 340B Drug Underpayment Fight

UNC Health has settled two lawsuits against Humana, alleging underpayment for drugs acquired through the federal 340B discount program. The settlement was noted in North Carolina federal court, indicating the resolution of the dispute concerning the drug pricing.

Bronstein, Gewirtz & Grossman, LLC Is Investigating Alignment Hea

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Alignment Healthcare, Inc. (NASDAQ:ALHC) following a whistleblower lawsuit. The lawsuit alleges that Alignment manipulated its finances by misclassifying operating expenses as capital expenditures to artificially inflate its adjusted EBITDA, leading to a significant drop …

Cigna’s Express Scripts Pressured Over TRICARE Contract in Senate Hearing

During a Senate hearing, Cigna's Express Scripts faced intense scrutiny regarding its TRICARE contract, with lawmakers raising concerns about potential overcharging of taxpayers and military families, and underpayment of independent pharmacies. Senators questioned the company's contract provisions allowing retroactive reimbursement adjustments and the inherent …

Bernstein Adjusts UnitedHealth Price Target to $512 From $492, Maintains Outperform Rating

Bernstein has increased its price target for UnitedHealth Group Inc. (UNH) to $512, up from the previous $492. The firm reiterated an "Outperform" rating on the stock. This adjustment reflects Bernstein's continued positive outlook on the managed healthcare provider.